Physician profile
Rakesh Reddy Devireddy
NPI 1093381964
$2,274.86
in general payments reported to CMS, 2019-2025
18 companies · $1,288 in 2025
The $1,288 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $986 · 2025: $1,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,274.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $577.71 | 2024-2025 | Lifevest |
| Stryker Corporation | $405.06 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Inari Medical, INC. | $369.31 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $307.16 | 2024-2025 | Impella |
| Bridgebio Pharma, INC. | $103.45 | 2025 | Attruby |
| Biotronik INC. | $101.24 | 2025 | Acticor 7 Vr-T Dx |
| Cordis US Corp. | $87.52 | 2024-2025 | Mynx Control, Aviator |
| Medtronic, INC. | $53.37 | 2024-2025 | Turbohawk, Micra |
| Terumo Medical Corporation | $39.83 | 2024-2025 | Angio-Seal, Metacross Otw, Tr Band |
| Novartis Pharmaceuticals Corporation | $38.36 | 2024 | |
| Alnylam Pharmaceuticals INC. | $37.35 | 2025 | Amvuttra |
| Reflow Medical INC | $33.77 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $24.50 | 2025 | Wainua |
| Genentech USA, INC. | $23.85 | 2024 | Columvi, Polivy, Lunsumio |
| Merck Sharp & Dohme LLC | $22.25 | 2025 | Verquvo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $19.45 | 2025 | |
| Pfizer INC. | $15.65 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.03 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Reddy Devireddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.